Clinical trial / 2015
A gut microbiota-targeted dietary intervention altered fecal menaquinones, which were linked to specific bacterial taxa but not cardiometabolic markers.
Researchers evaluated fecal menaquinone profiles, gut microbiota structure, and cardiometabolic biomarkers in 77 overweight Chinese adults consuming a prescribed diet designed to alter gut microbiota composition. Covariance among fecal menaquinones identified two distinct groups ('menaquinotypes'), characterized by differences in MK5, MK9-MK13, and relative abundance of species mostly within Prevotella and Bacteroides. During the intervention, fecal MK4, MK6, and MK8 decreased (P < 0.05), and longitudinal shifts in >100 operational taxonomic units related to altered individual menaquinones. However, neither individual menaquinones nor menaquinotypes were longitudinally associated with markers of glycemia, insulin resistance, or inflammation.
- Study type
- Intervention trial with periodic fecal sampling
- Who was studied
- 77 overweight Chinese adults
- What was measured
- Fecal menaquinone profiles, gut microbiota composition, and biomarkers of cardiometabolic health (glycemia, insulin resistance, inflammation)
THE PAPER
Fecal menaquinone profiles of overweight adults are associated with gut microbiota composition during a gut microbiota-targeted dietary intervention.
Karl JP, Fu X, Wang X, Zhao Y, Shen J, Zhang C, Wolfe BE, Saltzman E, Zhao L, Booth SL. Am J Clin Nutr, 2015.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.